EUVIMEDEUVIMED entdecken
MetaanalyseVergleichsstudieOpen Access · CC BY 4.0

Laparoscopic versus open surgery for rectal cancer: individual patient data meta-analysis of the ALaCaRT and Z6051 randomized trials

Kilian G M Brown iD, Andrew R L Stevenson, Michael J Solomon iD, James Murray, Kate Wilson, Val Gebski iD, James Fleshman, Qian Shi iD, Thomas E Read, John Simes

BJS Open · 03.07.2026 · 10 (4)

DOI: 10.1093/bjsopen/zrag119 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift BJS Open, online erschienen am 07.08.2026. Verfasst von Kilian G M Brown und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Rectal Neoplasms, Laparoscopy, Proctectomy, Adenocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Health and Medical Research Council, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The multicentre ALaCaRT and ACOSOG Z6051 randomized trials were unable to demonstrate non-inferiority of laparoscopic versus open surgery for rectal cancer with respect to a composite pathology metric indicating successful resection. Neither trial was individually powered to detect differences in long-term recurrence or survival. This planned meta-analysis determined long-term oncological outcomes of laparoscopic versus open proctectomy for rectal adenocarcinoma.

Methods

This prospective meta-analysis included individual patient data from patients with cT1–3 N0–2 M0 rectal adenocarcinoma enrolled in the ALaCaRT and ACOSOG Z6051 trials. Pathologically successful resection was defined as complete or near-complete total mesorectal excision, a clear circumferential resection margin (CRM; > 1 mm), and a clear distal resection margin (> 1 mm). The non-inferiority margin for disease-free survival (DFS) was an absolute difference of 5% at least 3 years after surgery.

Results

The combined data set included 935 patients (65.6% men, mean age 60.7 years, mean body mass index 26.7 kg/m2) randomized to open (457 patients) or laparoscopic (478 patients) proctectomy. Pathologically successful resection was lower in the laparoscopic than open group (85.1% versus 89.9%, respectively; pooled estimate 4.6% difference; 95% confidence interval (c.i.) −8.6% to −0.5%). The median follow-up was 60.2 (interquartile range 49.9–61.1) months. Three-year DFS was 75.2% (95% c.i. 71.1% to 79.2%) and 76.5% (95% c.i. 72.5% to 80.6%) for the laparoscopic and open groups, respectively (pooled estimate difference −1.5%; 95% c.i. −7.2% to 4.2%). Non-inferiority of laparoscopic surgery was not demonstrated because the lower one-sided 95% c.i. (−6.3% to 100%) crossed −5%. Three-year locoregional recurrence was higher in laparoscopic than open group (5.4% (95% c.i. 3.3% to 7.5%) versus 2.0% (95% c.i. 0.7% to 3.4%), respectively; pooled estimate 3.1% difference (95% c.i. 0.6% to 5.6%)). A clear CRM was the most significant and only pathological predictor of both DFS (P < 0.0001) and overall survival (P < 0.0001).

Conclusion

Laparoscopic proctectomy led to a lower rate of pathologically successful resection and a higher rate of locoregional recurrence at 3 years. The possibility of subsequent poorer DFS or overall survival rate requires further evaluation, because this analysis was not specifically powered for these endpoints.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsLaparoscopyProctectomyAdenocarcinomaHumansRandomized Controlled Trials as TopicDisease-Free SurvivalMiddle AgedFemaleMaleNeoplasm Recurrence, LocalProspective StudiesTreatment OutcomeMargins of ExcisionAged

Stichwörter der Autor:innen

laparoscopic surgeryproctectomytotal mesorectal excision

Autor:innen und Institutionen

  • Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • Surgical Outcomes Research Centre (SOuRCe) and Institute of Academic Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • Faculty of Medicine and Health, Central Clinical School, University of Sydney, Sydney, New South Wales, Australia.
  • Department of Colorectal Surgery, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Faculty of Health, Medicine and Behavioural Sciences, University of Queensland, Brisbane, Queensland, Australia.
  • Faculty of Medicine and Health, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia.

ORCID-Profile: Kilian G M Brown, Michael J Solomon, Val Gebski, Qian Shi

Förderung

  • NIH HHS
  • National Health and Medical Research Council
  • NCI NIH HHS
  • Colorectal Surgical Society of Australia and New Zealand
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Brown, K. G. M., Stevenson, A. R. L., Solomon, M. J., Murray, J., Wilson, K., Gebski, V., Fleshman, J., Shi, Q., Read, T. E., & Simes, J. (2026). Laparoscopic versus open surgery for rectal cancer: individual patient data meta-analysis of the ALaCaRT and Z6051 randomized trials. BJS Open, 10(4). https://doi.org/10.1093/bjsopen/zrag119

Vancouver

Brown KGM, Stevenson ARL, Solomon MJ, Murray J, Wilson K, Gebski V, et al. Laparoscopic versus open surgery for rectal cancer: individual patient data meta-analysis of the ALaCaRT and Z6051 randomized trials. BJS Open. 2026;10(4). doi:10.1093/bjsopen/zrag119

BibTeX
@article{Brown2026,
  author = {Brown, Kilian G M and Stevenson, Andrew R L and Solomon, Michael J and Murray, James and Wilson, Kate and Gebski, Val and Fleshman, James and Shi, Qian and Read, Thomas E and Simes, John},
  title = {Laparoscopic versus open surgery for rectal cancer: individual patient data meta-analysis of the ALaCaRT and Z6051 randomized trials},
  journal = {BJS Open},
  year = {2026},
  volume = {10},
  number = {4},
  doi = {10.1093/bjsopen/zrag119}
}
Kostenlos starten →